Equities

Graybug Vision Inc

GRAY:NMQ

Graybug Vision Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.6625
  • Today's Change-0.018 / -2.59%
  • Shares traded13.15k
  • 1 Year change-47.83%
  • Beta--
Data delayed at least 15 minutes, as of Jan 30 2023 18:33 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • GRAY:NMQ price moved over -5.89% to 0.6811
  • GRAY:NMQ price rises above 15-day moving average to 0.7088 at 09:35 GMT
  • GRAY:NMQ price falls below 15-day moving average to 0.6811 at 09:30 GMT

Key statistics

As of last trade, Graybug Vision Inc (GRAY:NMQ) traded at 0.6625, 47.19% above the 52 week low of 0.4501 set on Dec 21, 2022.
52-week range
Today
0.4501Dec 21 20221.58Mar 21 2022
Markit short selling activity
Low
Med
High
Open0.7088
High0.7088
Low0.6535
Bid0.656
Offer0.67
Previous close0.6801
Average volume26.08k
Shares outstanding21.56m
Free float19.79m
P/E (TTM)--
Market cap14.66m USD
EPS (TTM)-1.72
USD
Data delayed at least 15 minutes, as of Jan 30 2023 18:33 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.